MTOR and Alzheimer disease: From a preclinical standpoint, rapamycin-induced inhibition of mTOR in the 3xTg-AD mouse model increased the abundance of autophagy-related proteins, while simultaneously reducing both soluble Aβ and tau levels (Caccamo et al., 2010).